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Abstract
OBJECTIVE: Retinoic acid has been shown to improve the aged-
appearing skin. However, less is known about the anti-ageing
effects of retinol (ROL, vitamin A), a precursor of retinoic acid, in
aged human skin in vivo. This study aimed to investigate the
molecular basis of ROL anti-ageing properties in naturally aged
human skin in vivo.
METHODS: Sun-protected buttock skin (76  6 years old, n = 12)
was topically treated with 0.4% ROL and its vehicle for 7 days.
The effects of topical ROL on skin epidermis and dermis were evalu-
ated by immunohistochemistry, in situ hybridization, Northern
analysis, real-time RT-PCR and Western analysis. Collagen fibrils
nanoscale structure and surface topology were analysed by atomic
force microscopy.
RESULTS: Topical ROL shows remarkable anti-ageing effects
through three major types of skin cells: epidermal keratinocytes,
dermal endothelial cells and fibroblasts. Topical ROL significantly
increased epidermal thickness by stimulating keratinocytes prolifer-
ation and upregulation of c-Jun transcription factor. In addition to
epidermal changes, topical ROL significantly improved dermal
extracellular matrix (ECM) microenvironment; increasing dermal
vascularity by stimulating endothelial cells proliferation and ECM
production (type I collagen, fibronectin and elastin) by activating
dermal fibroblasts. Topical ROL also stimulates TGF-b/CTGF path-
way, the major regulator of ECM homeostasis, and thus enriched
the deposition of ECM in aged human skin in vivo. 0.4% topical
ROL achieved similar results as seen with topical retinoic acid, the
biologically active form of ROL, without causing noticeable signs of
retinoid side effects.
CONCLUSION: 0.4% topical ROL shows remarkable anti-ageing
effects through improvement of the homeostasis of epidermis and
dermis by stimulating the proliferation of keratinocytes and
endothelial cells, and activating dermal fibroblasts. These data pro-
vide evidence that 0.4% topical ROL is a promising and safe treat-
ment to improve the naturally aged human skin.
Resume
OBJECTIF: L’acide retino€ıque a ete montre ameliorer l’apparence
de la peau a^gee. Cependant, on conna^ıt moins les effets anti-vieillis-
sement de retinol (ROL, de la vitamine A), un precurseur de l’acide
retino€ıque, dans la peau humaine in vivo. Cette etude visait a etu-
dier la base moleculaire des proprietes anti-vieillissement du retinol
de la peau humaine naturellement vieillie in vivo.
METHODES: La peau des fesses protegee des UV (76  6 ans, n =
12) a ete traitee par voie topique avec 0,4% ROL et son vehicule
pendant sept jours. Les effets du ROL topique sur l’epiderme et le
derme de la peau ont ete evalues par immunohistochimie, l’hybri-
dation in situ, l’analyse Northern, RT-PCR en temps reel, et analyse
Western. La structure des fibrilles de collagene a l’echelle
nanometrique et la topologie de surface ont ete analyses par micro-
scopie a force atomique.
RESULTATS: ROL par voie topique montre des effets anti-a^ge
remarquables a travers trois grands types de cellules de la peau: les
keratinocytes epidermiques, les cellules endotheliales et les fibro-
blastes dermiques. ROL topique augmente de maniere significative
l’epaisseur de l’epiderme en stimulant la proliferation des keratino-
cytes et une regulation positive du facteur de transcription c-Jun.
En plus des changements de l’epiderme, le ROL topique ameliore
significativement le microenvironnement de la matrice extracellu-
laire (ECM) dermique: augmentation de la vascularisation cutanee
par stimulation de la proliferation des cellules endotheliales et la
production d’ECM (collagene de type I, la fibronectine et l’elastine),
en activant les fibroblastes dermiques. Le ROL topique stimule ega-
lement la voie TGF-b / CTGF, le principal regulateur de l’homeosta-
sie ECM, et donc enrichit le depo^t d’ECM dans la peau a^gee
humaine in vivo. L’application topique de 0,4% ROL obtient des
resultats similaires a ceux observes avec l’acide retino€ıque topique,
la forme biologiquement active de ROL, sans provoquer de signes
apparents d’effets secondaires associes aux retino€ıdes.
CONCLUSION: L’application topique de 0,4% ROL montre des
effets remarquables anti-a^ge gra^ce a une amelioration de
l’homeostasie du derme et l’epiderme, en stimulant la proliferation
des keratinocytes et des cellules endotheliales, et l’activation des
fibroblastes dermiques. Ces donnees fournissent la preuve que l’ap-
plication topique de 0,4% ROL est un traitement prometteur et su^r
pour ameliorer la peau humaine vieillie naturellement.
Introduction
Human skin, like all other organs, undergoes natural ageing pro-
cess as a consequence of the passage of time [1]. In addition,
human skin, unlike other organs, continuously experience harmful
stress and damage from environmental sources such as solar UV
irradiation [2]. As skin changes are among the most visible signs
of ageing, skin is central in the social and visual experience. As
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such, skin appearance has a significant emotional and psychologi-
cal impact on our life quality. In clinically, aged skin has a signifi-
cant pathological impact on many age-related skin diseases,
notably impaired wound healing [3, 4] and promotion of cancer
development in elderly [5, 6].
Histological and ultrastructural studies have revealed skin
undergoes remarkable morphologic changes with ageing, which
are primarily characterized by thinner epidermis and dermis with
reduced numbers of epidermal keratinocytes and dermal stromal
cells, respectively [7, 8]. This age-related thinning of epidermis and
dermis is the major driving force for the aged-appearing skin in
elderly. It is well-documented that age-related thinning of the epi-
dermis significantly impairs skin function such as impaired skin
barrier function that forms a barrier to prevent water loss and pro-
tect against environmental insults. In addition to epidermis, aged
skin dermis became thin largely due to loss of collagen, the major
structural protein in skin. Age-related thinning of the dermis
increases fragility [9, 10], impaired vasculature support [11, 12],
poor wound healing [3, 4] and altered tissue microenvironment
that promotes cancer development [5, 6].
Anti-ageing preventative approaches have been proposed for the
purpose of rejuvenating aged human skin and preventing age-
related skin diseases. However, safe and effective therapies to
reverse the atrophy of aged skin do not exist currently. Topical reti-
noic acid has been shown to improve clinical features of aged
appearance by reduction in fine wrinkling, increased smoothness
and diminished hyperpigmentation [13]. However, the underlying
cellular and molecular mechanisms are remaining to be fully eluci-
dated. Moreover, in contrast to retinoic acid, there are limited stud-
ies describing the molecular basis of retinol (ROL, vitamin A), a
precursor of retinoic acid, anti-ageing effects in human skin in vivo.
As human skin has the capacity to convert ROL to its biologically
active metabolite retinoic acid, we investigated ROL anti-ageing
effects in aged human skin in vivo. Our results demonstrate that
topical application of 0.4% ROL shows remarkable anti-ageing
effects in aged human skin through improvement of both epidermis
and dermis and enhanced TGF-b/CTGF pathway. These data reveal
molecular basis of ROL anti-ageing effects and further suggest that
topical ROL is a promising and safe treatment to improve naturally
aged human skin.
Materials and methods
Procurement of human tissue samples and retinol treatment in
human skin in vivo
All procedures involving human volunteers were approved by the
University of Michigan Institutional Review Board, and all volunteers
provided written informed consent. Full thickness punch biopsies
(4 mm) were obtained from aged (76  6 years) healthy sun-pro-
tected buttock skin after topical treatment of vehicle (70% ethanal,
30% polyethylene glycol, and 0.05% butylated hydroxytoluene) and
(ROL, vitamin A, 0.4%) [14]. Vehicle and ROL were applied topically
to sun-protected buttock skin for 7 days under occlusion to prevent
loss and exposure to light.
Immunohistology
Immunohistology was performed as described previously [15].
Briefly, skin OCT-embedded cryo-sections (7 lm) were fixed in
paraformaldehyde. Subsequently, the slides were incubated for
1 hour at room temperature with normal control serum followed
by incubation of primary antibodies against Ki 67, CD31, type I
procollagen, fibronectin, TGF-b1 and CTGF/CCN2 (Santa Cruz
Biotechnology, Santa Cruz, CA, U.S.A.). To verify antibody speci-
ficity, antibodies were incubated with antigenic peptides (Santa
Cruz Biotechnology) for 30 min prior to addition to skin sections.
All sections were lightly counterstained with haematoxylin and
were mounted with mounting media (Vector Laboratories, Burlin-
game, CA, U.S.A.). The intensity of positive staining was quantified
by computerized image analysis (IMAGE-PRO PLUS software, version
4.1, Media Cybernetics, Rockville, MD, U.S.A.).
RNA isolation and Northern blot analysis
Total RNA from human skin was extracted with a commercial kit
(RNeasy Midi Kit; Qiagen, Chatsworth, CA, U.S.A.) according to
the manufacturer’s protocol. Samples of total RNA (30–50 lg)
were resolved by 1.2% agarose electrophoresis, transferred to nylon
membranes and hybridized with TGF-b1 [16] and CCN2 CTGF/
CCN2 [17] cDNA probes labelled with [32P]dCTP by random prim-
ing. Each blot was stripped and re-hybridized with 36B4 internal
control gene transcript to monitor the sample load in each lane.
The intensities of each band were quantified by STORM PhosphorI-
mager (Molecular Dynamics, Sunnyvale, CA, U.S.A.) and normal-
ized to the 36B4 gene transcript.
In situ hybridization
pCDNA3.1 (Invitrogen, Carlsbad, CA, U.S.A.) plasmids containing
human TGF-b1 and CTGF/CCN2 were linearized with NotI and
BamHI. Digoxigenin-containing sense and anti-sense riboprobes
were synthesized using SP6 and T7 ribonucleic polymerase. Frozen
skin sections (5lm) were mounted, fixed, treated and hybridized as
previously described [17]. The hybridization signals were detected
immunohistochemically by alkaline phosphatase-conjugated anti-
digoxigenin antibody.
RNA isolation and quantitative real-time RT-PCR
Total RNA was extracted from human skin by using a commercial
kit (RNeasy mini kit, Qiagen), as previously described [18]. 200 ng
total RNA was reverse transcribed using Taqman Reverse Transcrip-
tion kit (Applied Biosystems, Foster City, CA, U.S.A.). Real-time RT-
PCR was performed using a Taqman Universal PCR Master Mix kit
(Applied Biosystems) and 7700 Sequence Detector (Applied Biosys-
tems). All PCR primers and probes were purchased from Applied
Biosystems (Assays-on-DemandTM Gene Expression Products, Applied
Biosystems). Target gene mRNA levels were normalized to the
housekeeping gene 36B4 (a ribosomal protein used as an internal
control for quantitation) levels as an internal control.
Western blot analysis
Whole cell proteins were extracted from human skin dermis. The
epidermis was removed by cutting off epidermis at a depth of
1 mm using cryostat. Equal amounts of protein (~50 lg per lane)
were resolved by 6–12% gradient sodium dodecyl sulphate-polya-
crylamide (SDS) gel electrophoresis and transferred to polyvinyli-
dene difluoride membranes. Membranes were then blocked with
PBST (Phosphate Buffered Saline with 0.1% Tween 20) contain-
ing 5% non-fat milk for one hour at room temperature. Smad7
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primary antibody was generously provided by Dr. Ten Dijke (Leiden
University Medical Centrum, Leiden, Netherlands). Primary anti-
body was incubated for one hour at room temperature. The mem-
branes were washed three times with PBST solution and incubated
with rabbit secondary antibody for one hour at room temperature.
After washing three times with PBST, the membranes were devel-
oped with ECF (Vistra ECF Western blotting system, GE Health
Care, Piscataway, NJ, U.S.A.) following the manufacturer’s proto-
col. The membranes were scanned with a STORM PhosphorImager
(Molecular Dynamics, Sunnyvale, CA, U.S.A.), the intensities of
each band were quantified using IMAGEQUANT software (GE Health
Care, Piscataway, NJ, U.S.A.) and normalized to b-actin (control).
Atomic force microscopy (AFM) imaging
Human skin biopsies were embedded in OCT, and cryo-sections
(10 lm) were attached onto the microscope cover glass (1.2 mm
diameter, Fisher Scientific Co., Pittsburgh, PA, U.S.A.). These AFM
samples were allowed to air dry for at least 24 h before imaging
them to AFM analysis. Images were taken by Dimension Icon AFM
system (Bruker-AXS, Santa Barbara, CA, U.S.A.) using a silicon
AFM probe (PPP-BSI, force constant 0.01–0.5 Nm1, resonant fre-
quency 12–45 kHz, NANOSENSORSTM, Switzerland). AFM was con-
ducted at the Electron Microbeam Analysis Laboratory (EMAL),
University of Michigan College of Engineering, and analyzed using
Nanoscope Analysis software (Nanoscope Analysis v120R1sr3,
Bruker-AXS, Santa Barbara, CA, U.S.A.).
Statistical analysis
Comparisons between groups were determined with the Student’s t-
test. All P values are two-tailed, and considered significant when
P < 0.05.
Results
Topical ROL increases epidermal thickness and dermal vascularity
by proliferation of epidermal keratinocytes and dermal endothelial
cells, respectively, in aged human skin in vivo
As thin epidermis is a characteristic feature of aged human skin, we
found that epidermal thickness was greatly improved following ROL
treatment (Fig. 1A). Quantitative morphometric analyses revealed
that epidermal thickness was increased 2.1-fold by ROL treatment
(Fig. 1B). Consistent with thickened epidermis, keratinocyte prolifer-
ation, assessed by Ki67 immunostaining (Fig. 1C upper right panel),
was increased 12-fold by ROL treatment (Fig. 1D). Interestingly, in
addition to epidermal changes, we noticed topical ROL markedly
increased the proliferation of dermal stromal cells (Fig. 1C lower
right panel, Fig. 1E). No Ki67 positive cell was observed in vehicle-
treated aged skin dermis (Fig. 1C lower left panel, Fig. 1E). Ki67 posi-
tive staining cells were particularly strong in papillary dermis. To
confirm the identity of proliferating dermal stromal cells, we per-
formed double-label immunofluorescence staining. As papillary der-
mis contains rich vascular networks, we found the majority of Ki67
positive cells were stained with CD31, a marker of endothelial cells
(Fig. 1F). This result was further supported by increased prominence
of blood vessels, confirmed by CD31 immunostaining (Fig. 1G).
Quantitative analyses revealed that blood vessel formation was
increased 3.8-fold in ROL-treated aged human skin (Fig. 1H).
Together, these data indicate that topical ROL increases epidermal
thickness and dermal angiogenesis by stimulating the proliferation of
epidermal keratinocytes and dermal endothelial cells, respectively, in
aged human skin in vivo.
ROL improves dermal ECM microenvironment by stimulating the
expression of type I collagen, fibronectin and tropoelastin in aged
human skin in vivo
As thin dermis is a prominent feature of aged skin dermis, we ana-
lyzed the expression of major ECM proteins by immunohistochem-
istry. Type I procollagen is the precursor of mature type I collagen
fibrils. Compared with vehicle-treated aged skin, ROL treatment
increased type I collagen staining, the major structural protein in
skin (Fig. 2A, right panels). Type I procollagen positive staining
was particularly strong in epidermal and dermal junction (Fig. 1A
lower right panel). Quantitative analysis indicated that the amount
of staining was increased three-fold by topical ROL treatment
(Fig. 2B). In addition to type I collagen, topical ROL markedly
increased the expression of fibronectin (FN) (Fig. 2C, right panels)
and tropoelastin (Fig. 2E, right panels). Quantification indicated
that fibronectin (Fig. 2D) and elastin (Fig. 2F) staining were
increased 2.2-fold and four-fold, respectively. These data indicate
that topical ROL improves dermal ECM microenvironment by stim-
ulating the major ECM proteins in aged human skin in vivo.
Elevated epidermal-specific c-Jun transcription factor by topical
ROL in aged human skin in vivo
Next, we explored the potential mechanisms by which topical ROL
stimulates keratinocytes proliferation in aged human skin. It has
been reported that AP-1 transcription factor plays a major role in
keratinocytes proliferation in response to growth factors, cytokines
and various stimuli [2]. As AP-1 complex largely comprised of c-
Jun/c-fos, we examined the expression c-Jun and c-Fos in aged
human skin after topical ROL treatment. We found that topical
ROL markedly increased epidermal-specific c-Jun protein positive
staining (Fig. 3A right panel) along with significant epidermal
thickness. No c-Jun positive cell was observed in the dermis. Quan-
titative analyses revealed that c-Jun positive staining was increased
2.3-fold in ROL-treated aged human skin (Fig. 3A right panel). In
contrast, no change of c-Fos protein expression was observed by
topical ROL treatment (Fig. 3B). Western analysis further con-
firmed that whereas c-fos was constitutively expressed (Fig. 3D), c-
Jun protein was elevated three-fold (Fig. 3C) by topical ROL treat-
ment. These data suggest that topical ROL elevates epidermal-speci-
fic c-Jun transcription factor, which in turn drives epidermal
keratinocytes proliferation in aged human skin in vivo.
Elevated TGF-b/CTGF pathway by topical ROL in aged human skin
in vivo
Next, we explored the potential mechanisms by which ROL stimu-
lates dermal ECM production in aged human skin. We first exam-
ined whether topical ROL is able to activate dermal fibroblasts, the
major ECM-producing cells in skin, by staining with HSP47, the
marker of fibroblast activation [19]. We observed that topical ROL
markedly increased HSP47 positive staining, suggesting the activa-
tion of dermal fibroblasts in aged human skin in vivo. (Fig 4A, right
panel). Quantitative analyses revealed that HSP47-positive staining
was increased 3.8-fold in ROL-treated aged human skin (Fig. 4A
right panel).
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It has been well-documented that activated dermal fibroblasts
increase ECM production through TGF-b pathway, the major reg-
ulator of ECM production [20]. Therefore, we investigated the
possible involvement of TGF-b pathway in increased ECM produc-
tion by topical ROL in aged human skin. To test this possibility,
we examined the effect of topical ROL on TGF-b pathway com-
ponents such as TGF-b receptors, ligands and Smads proteins.
Interestingly, topical ROL significantly upregulated TGF-b1
mRNA and down-regulated the inhibitory Smad7, whereas other
TGF-b pathway components remained unchanged (Fig. 4B). To
further confirm these results, we performed In situ hybridization
and immunostaining of TGF-b1 and its downstream mediator
connective tissue growth factor (CTGF). In situ hybridization indi-
cated that intense staining of TGF-b1 (Fig. 4C) and CTGF/CCN2
(Fig. 4D). Quantification indicated that TGF-b1 (Fig. 4C right
panel) and CTGF (Fig. 4D right panel) dermal staining were
increased 3.1-fold and 2.8-fold, respectively, following topical
ROL treatment. Northern analysis further confirmed that TGF-b1
(Fig. 4E) and CTGF/CCN2 (Fig 4F) transcription were increased
2.6-fold and 3.8-fold, respectively, after topical ROL treatment.
Consistent with mRNA expression, immunostaining of TGF-b1
(Fig. 4G) and CTGF/CCN2 (Fig. 4H) were increased 2.7-fold and
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Figure 1 Topical ROL increases epidermal
thickness and dermal vascularity by prolifera-
tion of epidermal keratinocytes and dermal
endothelial cells, respectively, in aged human
skin in vivo. OCT-embedded skin sections
(7 lm) were obtained from aged
(76  6 years) healthy sun-protected buttock
skin after topical treatment of vehicle and 0.4%
retinol for 7 days. (A) H&E staining. Represen-
tative images of twelve individuals (n = 12).
White arrows indicate epidermal thickness.
Bars = 100 lm. (B) Quantification of epidermal
thickness (lm). (C) Ki67 immunostaining. 3.09
enlargement of the boxed region is shown to
lower panels. Bars = 100 lm. Red arrows indi-
cate Ki67 positive cells. Representative images
of twelve individuals (n = 12). Quantification of
epidermal (D) and dermal (E) Ki 67 immunos-
taining. (F) Ki67 and CD31 co-immunofluores-
cence staining. Skin sections were co-
immunofluorescence stained with Ki67 and
CD31, a marker of endothelial cells. Arrows
indicate double stained cells. Representative of
five individuals. Bar = 50 lm. (G) CD31
immunostaining. Representative images of
twelve individuals (n = 12). Bar = 100 lm. (H)
Quantification of CD31 immunostaining. All
immunostainings were quantified by computer-
ized image analysis (Image-pro Plus software,
version 4.1, Media Cybernetics, MD) and data
are expressed as mean  SEM, *P < 0.05.
n = 12.
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2.8-fold, respectively, after topical ROL treatment. We further
confirmed that ROL treatment significantly reduced Smad7
mRNA (Fig. 4I) and protein (Fig. 4J), a potent inhibitor of TGF-b
signalling. These data suggest that topical ROL stimulates dermal
fibroblasts ECM production through upregulation of TGF-b/CTGF
pathway in aged human skin.
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Figure 2 ROL improves dermal ECM microen-
vironment in aged human skin in vivo. OCT-
embedded skin sections (7 lm) were obtained
from aged (76  6 years) healthy sun-pro-
tected buttock skin after topical treatment of
vehicle and 0.4% retinol for 7 days. (A) Type I
procollagen immunostaining. 39 enlargement
of the boxed region is shown to lower panels.
Representative images of twelve individuals
(n = 12). Arrows indicate positive cells.
Bars = 100 lm. (B) Quantification of type I
procollagen. (C) Fibronectin immunostaining.
2.59 enlargement of the boxed region is shown
to lower panels. Representative images of
twelve individuals (n = 12). Arrows indicate
positive cells. Bars = 100 lm. (D) Quantifica-
tion of fibronectin. (E) Tropoelastin immunos-
taining. 3.09 enlargement of the boxed region
is shown to lower panels. Representative
images of twelve individuals (n = 12).
Bars = 100 lm. (F) Quantification of tropoe-
lastin. All immunostainings were quantified by
computerized image analysis (Image-pro Plus
software, version 4.1, Media Cybernetics, MD)
and data are expressed as mean  SEM,
*P < 0.05. n = 12.
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Topical ROL increases the deposition of mature collagen in aged
human skin in vivo
Having found that ROL is able to stimulate collagen production, we
next assessed the collagen fibrils nanoscale structure and surface
topology by (AFM). In vehicle-treated aged skin, collagen fibrils
appeared disorganized and fragmented (Fig. 5A, left panel). How-
ever, topical ROL-treated aged skin revealed highly organized,
dense bundles of collagen fibrils, with characteristic banded struc-
ture (D-spacing) representing the staggered alignment of individual
collagen molecules within fibrils (Fig. 5A, right panel). Three-
dimensional topographical AFM images further indicated that vehi-
cle-treated aged skin dermis was much rougher and uneven
(Fig. 5B, left panel). In contract, ROL-treated aged skin dermis was
smooth and flattened (Fig. 5B, right panel). Quantitative analysis of
AFM data indicated that the average roughness (a measure of fibril
organization) of dermal collagen fibrils in ROL-treated aged skin is
48% less than in vehicle-treated aged skin dermis (Fig. 5B, 16 nm
vs. 31 nm). These findings indicate that ROL treatment stimulates
synthesis of procollagen, which is processed into mature collagen
in aged human skin.
Discussion
Retinoids is the term used for the group of vitamin A derivatives
[21]. Retinoic acid is the biologically active form of vitamin A
which is also known as (ROL), a precursor to retinoic acid. Human
skin has the capacity to convert ROL to its biologically active
metabolite retinoic acid. When topically applied to human skin, it
penetrates and is sequentially converted to retinaldehyde and then
to retinoic acid. One important benefit of topical ROL is that com-
pared with retinoic acid, ROL induces fewer signs of side effects,
which is characterized by erythema, scaling, dryness and pruritis
[22, 23]. Our results indicate that although a much higher concen-
tration of ROL (0.4%) is needed to achieve similar results as seen
with topical retinoic acid, ROL induced the same histological
changes (epidermal hyperplasia and dermal ECM production) as
retinoic acid without causing retinoids irritation, the most common
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Figure 3 Elevated epidermal-specific c-Jun
transcription factor by topical ROL in aged
human skin in vivo. OCT-embedded skin sec-
tions (7 lm) were obtained from aged
(76  6 years) healthy sun-protected buttock
skin after topical treatment of vehicle and 0.4%
retinol for 7 days. (A) c-Jun immunostaining.
Representative images of twelve individuals
(n = 12). Bars = 100 lm. (B) c-Fos immunos-
taining. Representative images of twelve indi-
viduals (n = 12). Bars = 100 lm. All
immunostainings were quantified by computer-
ized image analysis (Image-pro Plus software,
version 4.1, Media Cybernetics, MD) and data
are expressed as mean  SEM, *P < 0.05.
n = 12. (C) c-Jun protein. (D) c-Fos protein.
Protein levels were determined by Western
analysis. Protein levels were normalized to b-
actin (loading control). Insets show representa-
tive Western blots. Mean  SEM, n = 6,
*P < 0.05.
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side effect of retinoids. Mechanistically, it appears that topical ROL
increases epidermal thickness by stimulating keratinocytes prolifer-
ation, which involves epidermal-specific upregulation of c-Jun tran-
scription factor. Topical ROL also significantly elevates ECM
production, which involves enhanced TGF-b/CTGF pathway in the
dermis. Additionally, topical ROL significantly increased dermal
vascularity which may have a significant impact on the homeosta-
sis of epidermis and dermis.
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Figure 5 Deposition of mature collagen is
increased by topical ROL in aged human skin
in vivo. OCT-embedded skin sections (7 lm)
were obtained from aged (76  6 years)
healthy sun-protected buttock skin after topical
treatment of vehicle and 0.4% retinol for
7 days. (A) Nanoscale collagen fibrils were
imaged by AFM. Representative AFM images
were shown. n = 12. The blue arrows indicate
intact collagen fibrils and red arrow heads indi-
cate damaged collagen fibrils. (B) Three-dimen-
sional collagen fibrils. Dermal roughness was
analyzed using Nanoscope Analysis software
(Nanoscope_Analysis_v120R1sr3, Bruker-AXS,
Santa Barbara, CA). All results are expressed as
the mean  SEM, n = 12, *P < 0.05.
Bars = 100 nm. (C) Proposed model for topical
ROL exerts anti-ageing effects in aged human
skin by proliferation of epidermal keratinocytes
and dermal endothelial cells and activation of
dermal fibroblasts (see Discussion for details).
Figure 4 Topical ROL stimulates TGF-b/CTGF pathway, the major regulator of ECM homeostasis, in aged human skin in vivo. OCT-embedded skin sections
(7 lm) were obtained from aged (76  6 years) healthy sun-protected buttock skin after topical treatment of vehicle and 0.4% retinol for 7 days. (A) HSP47
immunostaining. Representative images of twelve individuals (n = 12). Bars = 100 lm. (B) TGF-b pathway components mRNA levels. Total RNA was prepared
from human skin samples. mRNA levels were determined by real-time RT-PCR. mRNA levels were normalized to 36B4 (internal housekeeping gene control).
Mean  SEM, n = 12, *P < 0.05. (C) TGF-b1 (D) CTGF/CCN2 in situ hybridization. Representative images of twelve individuals (n = 12). Bars = 100 lm. (E)
TGF-b1 (F) CTGF/CCN2 Northern analysis. The intensities were quantified and normalized using 36B4 as loading control. Insets show representative Northern
blots. Data are expressed as mean  SEM, *P < 0.05. n = 12. (G) TGF-b1 (H) CTGF/CCN2 immunostaining. Representative images of twelve individuals (n = 12).
Bars = 100 lm. (I) Smad7 Northern analysis. The intensities were quantified and normalized using 36B4 as loading control. Inset shows representative Northern
blots. Data are expressed as mean  SEM, *P < 0.05. n = 12. (J) Smad7 protein. Smad7 protein levels were determined by Western analysis. Protein levels were
normalized to b-actin (loading control). Insets show representative Western blots. Mean  SEM, n = 6, *P < 0.05. All positive staining was quantified by comput-
erized image analysis (Image-pro Plus software, version 4.1, Media Cybernetics, MD). Data are expressed as mean  SEM, *P < 0.05. n = 12.
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Although topical retinoids have been widely used in the treatment
of skin ageing, the precise mechanism(s) by which retinoids lead to
visible improvement in aged skin is not fully understood. One signifi-
cant finding of our study is that topical ROL improves aged dermal
ECM microenvironment through enhancement of TGF-b/CTGF path-
way in the dermis, the principle regulator of ECM homeostasis [20].
ROL is able to enhance TGF-b/CTGF pathway through two indepen-
dent pathways: increases of the expression of TGF-b1/CTGF and sup-
pression of inhibitory Smad7 of TGF-b signalling (Fig. 4). In primary
human skin fibroblasts, the major ECM-producing cells in skin, the
expression of major ECM proteins is regulated by TGF-b/CTGF path-
way [7, 20]. For example, neutralization of endogenous TGF-b or
knockdown of CTGF substantially reduced the expression of type I
procollagen and fibronectin mRNA and protein. In contrast, overex-
pression of inhibitory Smad7, which is significantly reduced by topi-
cal ROL (Fig. 4B, I, J), abolished TGF-b or CTGF stimulation of ECM
production. Importantly, we have previously reported that TGF-b/
CTGF pathway is significantly reduced in dermal fibroblasts, in aged
(80+years) human skin in vivo [7, 20, 24, 25]. This impaired TGF-b/
CTGF pathway in aged human skin is largely caused by reduced
expression of TGF-b1 and CTGF. As impaired TGF-b/CTGF pathway
significantly contributes to thinned dermis, our data suggest that the
ability of topical ROL to improve aged skin dermis involves enhanced
TGF-b/CTGF pathway.
Reduced vasculature and epidermal thinning contribute signifi-
cantly to skin fragility and impaired wound healing in aged skin
[26, 27]. AP-1 transcription factor plays a major role in ker-
atinocytes proliferation [13]. We found that whereas c-Fos is con-
stitutively expressed in human skin, topical ROL elevates
epidermal-specific c-Jun transcription factor. These data suggest
that topical ROL may stimulate keratinocytes proliferation by epi-
dermal-specific upregulation c-Jun transcription factor in aged
human skin. Our study added another new piece of information
that topical ROL improves dermal microenvironment through not
only stimulation of ECM production, but also expansion of vascula-
ture by proliferation of endothelial cells in aged human skin
(Fig. 1C, F, G). A reduction of the cutaneous vasculature has been
reported in aged human skin [27]. Increased vascularity of the der-
mis by topical ROL could increase skin blood flow and provide a
more suitable microenvironment for the homeostasis of skin epider-
mal and dermal homeostasis. In contrast, it is also conceivable that
proliferation of epidermal keratinocytes and restoration of ECM pro-
duction by topical ROL may provide a more favourable microenvi-
ronment for the proliferation of endothelial cells and dermal
vasculature. Indeed, epidermal keratinocytes are important source
of vascular endothelial growth factor (VGEF), a potent angiogenic
factor [27]. Additionally, it has been reported that enhanced der-
mal ECM production resulted in stimulation of endothelial cell pro-
liferation [19]. Clearly, additional studies are warranted to uncover
the precise molecular mechanism(s) by which topical ROL stimu-
lates the proliferation of epidermal keratinocytes and dermal
endothelial cells in aged human skin. The molecular mechanisms
by which retinoids improve aged human skin have been difficult to
investigate largely due to lack of appropriate in vitro models. For
example, cells in both the epidermis and dermis contain all the pro-
teins and receptors that mediate the biological effects of vitamin A
metabolites in the skin. However, primary keratinocytes or dermal
fibroblasts are minimally responsive to RA treatment in monolayer
culture [14, 28]. This lack of responsiveness is due, at least in part,
to low levels of nuclear retinoid receptors, which mediate expres-
sion of retinoid-regulated genes [29, 30]. Skin equivalent cultures
could be a useful model to investigate retinoids regulation of colla-
gen homeostasis [14]. Skin equivalent cultures are composed of
stratified, differentiated keratinocytes (model epidermis) on top of a
type I collagen lattice, in which dermal fibroblasts are embedded
(model dermis). Treatment of skin equivalent cultures with retinoic
acid significantly increased the number of keratinocyte layers and
dermal response, similar to the effect of topical application of RA to
human skin in vivo. These data suggest that skin equivalent cul-
tures could be a useful model for investigating mechanisms by
which retinoids improve aged-appearing skin in human.
Together, our findings extend current knowledge of retinoids
anti-ageing mechanisms in aged human skin. We propose a work-
ing model for the molecular basis of ROL anti-ageing properties in
aged human skin (Fig. 5C). Topical application of 0.4% ROL to
aged human skin leads to remarkable skin changes in both epider-
mis and dermis through affecting three major types of skin cells,
epidermal keratinocytes, dermal endothelial cells and fibroblasts.
Topical ROL significantly increases epidermal thickness by stimulat-
ing epidermal keratinocytes proliferation, which involves c-Jun
transcription factor, a major driving force for keratinocyte prolifera-
tion. In addition to epidermal changes, topical ROL significantly
improves dermal ECM microenvironment; increasing dermal blood
vessel formation by stimulating endothelial cells proliferation and
ECM production by activating fibroblasts. Topical ROL also stimu-
lates TGF-b/CTGF pathway, the major regulator of ECM homeosta-
sis, and thus increased the deposition of mature collagen in aged
human skin in vivo.
Increased dermal vasculatures could increase skin blood flow
and provide a more active microenvironment for both epidermal
keratinocyte proliferation and dermal fibroblasts activation. On
the other hand, the proliferation of epidermal keratinocytes may
also promote dermal blood vessel growth through stimulation of
VEGF expression [27]. Additionally, the restoration of dermal ECM
may provide a better, more permissive environment for the prolif-
eration of dermal endothelial cells and epidermal keratinocytes,
and activation of dermal fibroblasts (TGF-b/CTGF pathway) [19].
We propose that coupling of the proliferation of keratinocytes and
endothelial cells, and dermal fibroblasts activation forms a self-
enforcing environment, which might explain the remarkable anti-
ageing effects of ROL in aged human skin. Proposed model
extends current understanding of the ROL anti-ageing mecha-
nisms in human skin.
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